Chang M, Lin S, Wu S, Yang W
Sci Rep. 2020; 10(1):15557.
PMID: 32968161
PMC: 7511931.
DOI: 10.1038/s41598-020-72568-5.
Ghosh C, Abdelkhalek A, Mohammad H, Seleem M, Haldar J
Sci Rep. 2020; 10(1):5624.
PMID: 32221399
PMC: 7101335.
DOI: 10.1038/s41598-020-62496-9.
Aizawa K, Kawasaki R, Tashiro Y, Shimonaka Y, Hirata M
BMC Nephrol. 2018; 19(1):19.
PMID: 29374477
PMC: 5787256.
DOI: 10.1186/s12882-018-0818-4.
Korell J, Vos F, Coulter C, Schollum J, Walker R, Duffull S
J Pharmacokinet Pharmacodyn. 2011; 38(6):787-801.
PMID: 21997468
DOI: 10.1007/s10928-011-9220-6.
Tennankore K, Soroka S, West K, Kiberd B
BMC Nephrol. 2011; 12:19.
PMID: 21569355
PMC: 3114714.
DOI: 10.1186/1471-2369-12-19.
Human recombinant erythropoietin therapy in a cat with chronic renal failure.
Bloomberg R, Pook H, Jacobs R, Van Gorder J
Can Vet J. 1992; 33(9):612-3.
PMID: 17424079
PMC: 1481339.
Ferrokinetics in patients on CAPD: influence of CAPD on the anemia of uremia.
Lee H, Koh S, Park H
Korean J Intern Med. 1986; 1(1):54-9.
PMID: 15759377
PMC: 4534904.
DOI: 10.3904/kjim.1986.1.1.54.
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.
Whittington R, Barradell L, Benfield P
Pharmacoeconomics. 1992; 3(1):45-82.
PMID: 10146987
DOI: 10.2165/00019053-199303010-00006.
End-stage kidneys are capable of increased erythropoietin production.
Morris K, Coulthard M
Pediatr Nephrol. 1993; 7(3):273-5.
PMID: 8518097
DOI: 10.1007/BF00853219.
Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.
Perna A, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo N
J Clin Invest. 1993; 91(6):2497-503.
PMID: 8514862
PMC: 443310.
DOI: 10.1172/JCI116485.
An outbreak of Heinz body positive hemolytic anemia in chronic hemodialysis patients.
Pyo H, Kwon Y, Wee K, Kwon S, Lee C, Kim S
Korean J Intern Med. 1993; 8(2):93-8.
PMID: 8031729
PMC: 4532089.
DOI: 10.3904/kjim.1993.8.2.93.
Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure.
Radtke H, Rege A, Lamarche M, Bartos D, BARTOS F, Campbell R
J Clin Invest. 1981; 67(6):1623-9.
PMID: 7240411
PMC: 370736.
DOI: 10.1172/jci110197.
Effect of parathyroid hormone on erythropoiesis.
Meytes D, Bogin E, Ma A, DUKES P, Massry S
J Clin Invest. 1981; 67(5):1263-9.
PMID: 7229028
PMC: 370692.
DOI: 10.1172/jci110154.
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.
Eschbach J, Mladenovic J, Garcia J, Wahl P, Adamson J
J Clin Invest. 1984; 74(2):434-41.
PMID: 6746902
PMC: 370494.
DOI: 10.1172/JCI111439.
Zinc in patients with chronic renal failure.
Piechota W, Dobrucki T, SYMONOWICZ N, Wadowska E, Murkowska E
Int Urol Nephrol. 1983; 15(4):377-82.
PMID: 6662654
DOI: 10.1007/BF02082558.
Effect of parathyroid hormone on osmotic fragility of human erythrocytes.
Bogin E, Massry S, Levi J, DJALDETI M, Bristol G, Smith J
J Clin Invest. 1982; 69(4):1017-25.
PMID: 6281309
PMC: 370157.
DOI: 10.1172/jci110505.
Biochemical consequences of chronic renal failure: a review.
Wills M
J Clin Pathol. 1968; 21(5):541-54.
PMID: 4880410
PMC: 473860.
DOI: 10.1136/jcp.21.5.541.
Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
Akmal M, Telfer N, Ansari A, Massry S
J Clin Invest. 1985; 76(4):1695-8.
PMID: 4056047
PMC: 424168.
DOI: 10.1172/JCI112157.
Erythropoietin: the developing story.
COTES P
Br Med J (Clin Res Ed). 1988; 296(6625):805-6.
PMID: 3130919
PMC: 2545097.
DOI: 10.1136/bmj.296.6625.805.
Serum selenium levels in healthy adults and its changes in chronic renal failure.
Kostakopoulos A, Kotsalos A, Alexopoulos J, Sofras F, Deliveliotis C, KALLISTRATOS G
Int Urol Nephrol. 1990; 22(4):397-401.
PMID: 2228503
DOI: 10.1007/BF02549802.
